Injectable Drug Delivery Conference 2018

Injectable Drug Delivery Conference is organized by SMi Group and will be held during May 15 - 17, 2018 at Holiday Inn London - Kensington Forum, London, England, United Kingdom.

The Global Injectable Drug Delivery Market is expected to reach $789.7 billion USD by 2024, with a compound annual growth rate (CAGR) of 11.5% during the period of 2017 to 2024, according to Research Markets Reports. Therefore, this conference will aim to discuss the key developments in this field and the latest technological advancements.

How Will You Benefit?

• Network and learn from leading professionals such as:
• Review device designs for a future portfolio
• Explore risk management options for combination products
• Hear how companies are tackling compatibility challenges of biologics with high volume injectors
• Learn how vial-based novel delivery technologies can overcome complex dosing regiments

Featured Highlights:

• Review device designs for a future portfolio
• Explore risk management options for combination products
• Hear how companies are tackling compatibility challenges of biologics with high volume injectors
• Learn how vial-based novel delivery technologies can overcome complex dosing regiments
• Discover how nanosystems can help address present and future challenges in injectable peptide delivery

Topics that will be covered include:

• Emerging technologies and opportunities
• Developing the next generation of devices
• Advancing the fill and finish process
• Revolutionizing the patient experience
• Developing better biologics
• Design considerations

Featured Speakers:

• Anand Subramony, Vice President, Novel Product Technologies, MedImmune
• Mostafa Nakach, Head of Pharmaceutical Engineering, Sanofi
• Maxime Gaillot, Senior Device Engineer, Roche
• Pierre Goldbach, Senior Principal Scientist, Late-Stage Pharmaceutical and Processing Development, F. Hoffmann-La Roche AG
• Fie Falck Larsen, Senior Usability Engineer, Injection Devices, Global Research and Development, LEO Pharma
• Francesco Malavasi, Medical Device Quality Device Risk Manager, Novartis

Price:
Standard Price (early-bird rates available): GBP 1499

Additional details will be posted as soon as they are available.